Treatment of left accessory cardiac pathway conduction disorders using radiofrequency catheter ablation under the guidance of the Ensite NavX 3D mapping system: a retrospective study
- 72 Downloads
To investigate the effectiveness and safety of using the Ensite NavX three-dimensional (3D) mapping system during Radiofrequency catheter ablation (RFCA) of left accessory pathway (AP) disorders. A total of 227 patients having their left AP treated by RFCA, were classified into study group (n = 112) and the control group (n = 115). X-ray irradiation time and exposure doses during the course of the operations were recorded. Time taken to place the mapping catheter along with total duration of operations and procedural complications were compared. The X-ray irradiation time and exposure doses in the course of manipulating the ablation catheters were significantly lower in the study group compared to control (5.1 ± 2.3 min vs. 13.1 ± 3.1 min; P < 0.05 and 5.7 ± 2.6 mGy vs. 17.8 ± 4.3 mGy; P < 0.05, respectively). The total duration of operation was also significantly shorter in the study group compared to control (53.1 ± 18.8 min vs. 62.3 ± 20.6 min; P < 0.05). No procedural complications were reported in both groups. The irradiation time and exposure dose along with total operation duration was significantly reduced when the Ensite NavX mapping system was used during RFCA in comparison with traditional X-ray fluoroscopy method.
KeywordsThree-dimensional mapping system Radiofrequency catheter ablation Left accessory pathway X-ray irradiation
This research received no specific funding.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 12.Casella M, Pelargonio G, Dello Russo A et al (2011) “Near-zero” fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX™ mapping system: personal experience and review of the literature. J Interv Card Electrophysiol 31:109–118. https://doi.org/10.1007/s10840-011-9553-5 CrossRefGoogle Scholar
- 15.Huo Y, Christoph M, Forkmann M et al (2015) Reduction of radiation exposure during atrial fibrillation ablation using a novel fluoroscopy image integrated 3-dimensional electroanatomic mapping system: a prospective, randomized, single-blind, and controlled study. Heart Rhythm 12:1945–1955. https://doi.org/10.1016/j.hrthm.2015.05.018 CrossRefGoogle Scholar
- 16.Papagiannis J, Avramidis D, Alexopoulos C, Kirvassilis G (2011) Radiofrequency ablation of accessory pathways in children and congenital heart disease patients: impact of a nonfluoroscopic navigation system. Pacing Clin Electrophysiol 34:1288–1396. https://doi.org/10.1111/j.1540-8159.2011.03170.x CrossRefGoogle Scholar
- 19.Jin-rui G, Lihui Z, Yan Y et al (2016) Total three-dimensional electrophysiology mode:a single-center experience of 5093 patients. Chin J Cardiac Arrhythm 20:187–193Google Scholar
- 20.Bingbo H, Yan Y, Kuijun Z et al (2014) Reducing radiation dose during catheter ablation of paroxysmal supraventricular tachycardia. Chin J Cardiac Arrhythm 18:353–356Google Scholar
- 21.Patel SM, McLeod CJ, Friedman PA et al (2011) Successful ablation of a left-sided accessory pathway in a patient with coronary sinus atresia and arteriovenous fistula: clinical and developmental insights. Indian Pacing Electrophysiol J 11:43–49Google Scholar
- 24.Seizer P, Bucher V, Frische C et al (2016) Efficacy and safety of zero-fluoroscopy ablation for supraventricular tachycardias. Use of optional contact force measurement for zero-fluoroscopy ablation in a clinical routine setting. Herz 41:241–245. https://doi.org/10.1007/s00059-015-4358-4 CrossRefGoogle Scholar